NIH SBIR-STTR
South Rampart Pharma receives $1.9M NIH STTR Fast-Track Grant

PAIN RELIEF INNOVATION

South Rampart Pharma is committed to improving the lives of people suffering from acute, chronic and neuropathic pain by developing a new class of non-opioid pain medicines that do not have the toxicities found in current over the counter and prescription medicines.

Watch our video

South Rampart Pharma is advancing the treatment of pain by developing new, small-molecule solutions that have the potential to overcome many risks associated with current pain medicines.

Technology

Pipeline

Global Need